Redmile Group, LLC

LARKSPUR, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.37B2026 Q3
Positions44
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.71.6%

Redmile Group, LLC reported 44 positions worth $1.37B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: NRIX (13.7%). Biggest move: add NRIX ($90.7M).

10 / 44 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 NRIXNurix Therapeutics$187.3M13.71%7,901,085——-37.9%
▸ 2 KRYSKrystal Biotech$175.5M12.84%527,684——-10.4%
▸ 3 SRRKScholar Rock$146.6M10.73%3,033,962——-7.8%
▸ 4 STOKStoke Therapeutics$100.6M7.36%3,869,028——+2.4%
▸ 5 IMNMImmunome$93.8M6.87%4,363,064——-12.7%
▸ 6 ABSIAbsci$71.9M5.26%6,671,377——-30.6%
▸ 7 ETRAElectra Therapeutics$61.1M4.47%5,430,918——-26.1%
▸ 8 ANNXAnnexon$60.4M4.42%14,278,075——-15.6%
▸ 9 NGNENeurogene$43.5M3.18%1,562,199——-14.0%
▸ 10 RGNXRegenxbio$38.0M2.78%5,048,502——-2.8%

Pro Feature

The remaining 34 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Redmile Group, LLC hold as of Q3 2026?

Redmile Group, LLC reported 44 positions worth $1.37B in its Q3 2026 13F filing. Largest positions: NRIX (13.7%), KRYS (12.8%), SRRK (10.7%), STOK (7.4%) and IMNM (6.9%).

What did Redmile Group, LLC buy in Q3 2026?

New positions: ETRA, ATTOVIA THERAPEUTICS INC, ADRX, OBX and TCGX ACQUISITION CORP (6 in all). Added to: NRIX, ANNX, RGNX, NGNE and SLN (7 in all).

What did Redmile Group, LLC sell in Q3 2026?

Reduced: SRRK, KRYS, STTK, IMNM and AGMB (26 in all). Sold out entirely: ESTA.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.